Kava

Volver al artículo.

Referencias para el artículo

  1. Bone K. Kava: A safe herbal treatment for anxiety. Br J Phytother 1994;3:145–53.
  2. Blumenthal M, Busse WR, Goldberg A, et al. eds. The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 156–7.
  3. Buckley JP, Furgiuele AR, O’Hara MJ. Pharmacology of kava. In Ethnopharmacoligcal Search for Psychoactive Drugs, DH Efron, B Holmstedt, NS Kline, eds. New York: Raven Press, 1979, 141–51.
  4. Holm E, Staedt U, Heep J, et al. Studies on the profile of the neurophysiological effects of D,L-kavain: Cerebral sites of action and sleep-wakefulness-rhythm in animals. Arzneimittlforschung 1991;41:673–83.
  5. Munte TF, Heinze HJ, Matzke M, Steitz J. Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word-recognition task. Pharmacoelctroencephalog 1993;27:46–53.
  6. Piscopo G. Kava kava: Gift of the islands. Alt Med Rev 1997;2:355–81 [review].
  7. Lehmann EE, Kinzler J, Friedmann J. Efficacy of a special kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin. A double-blind placebo-controlled study of four weeks treatment. Phytomedicine 1996;3:113–9.
  8. Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders. A randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry 1997;30:1–5.
  9. Warnecke G. Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of kava extract WS 1490. Fortschr Med 1991;119–22 [in German].
  10. De Leo V, la Marca A, Morgante G, et al. Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety. Maturitas 2001;39:185–8.
  11. Woelk H, Kapoula S, Lehrl S, et al. Treatment of patients suffering from anxiety—double-blind study: Kava special extract versus benzodiazepines. Z Allegemeinmed 1993;69:271–7.
  12. Brown DJ. Herbal Prescriptions for Better Health. Rocklin, CA: Prima Publishing, 1996, 145–50.
  13. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 156–7.
  14. Stafford, Ned. Germany may ban kava kava herbal supplement. Reuters, Nov. 19, 2001. http://www.reutershealth.com/frame2/eline.html
  15. Blumenthal M (Ed.). The Complete German Commission E Monographs. American Botanical Council, Boston, MA, 1998:156–7.
  16. Escher M, Desmeules J, Giostra E, Mentha G. Hepatitis associated with kava, a herbal remedy for anxiety. BMJ 2001;322:139.
  17. Kraft M, Spahn TW, Menzel J, et al. Fulminant liver failure after administration of the herbal antidepressant Kava-Kava. Dtsch Med Wochenschr 2001;126:970–2 [in German].
  18. Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal remedies. Dtsch Med Wochenschr 1998;123:1410–4 [in German].
  19. Russmann S, Lauterburg BH, Helbling A. Kava hepatotoxicity. Ann Intern Med 2001;135:68–9 [letter].
  20. Information provided by the German Federal Institute for Drugs and Medical Devices.
  21. Mathews JD, Riley MD, Fejo L, et al. Effects of the heavy usage of kava on physical health: summary of a pilot survey in an aboriginal community. Med J Aust 1988;148:548–55.
  22. Schroder-Bernhardi D, Dietlein G. Compliance with prescription recommendations by physicians in practices. Int J Clin Pharmacol Ther 2001;39:477–9.
  23. Escher M, Desmeules J, Giostra E, Mentha G. Hepatitis associated with kava, a herbal remedy for anxiety. BMJ 2001;322:139.
  24. Jappe U, Franke I, Reinhold D, Gollnick HPM. Sebotropic drug reaction resulting from kava-kava extract therapy: A new entity? J Amer Acad Dermatol 1998;38:104–6.
  25. Schmidt P, Boehncke WH. Delayed-type hypersensitivity reaction to kava-kava extract. Contact Derm 2000;42:363–4.
  26. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 156–7.
  27. Foo H, Lemon J. Acute effects of kava, alone or in combination with alcohol, on subjective measures of impairment and intoxication and on cognitive performance. Drug Alcohol Rev 1997;16:147–55.
  28. Almeida JC, Grimsley EW. Coma from the health food store: Interaction between kava and alprazolam. Arch Intern Med 1996;125:940–1.
  29. Herberg KW. Driving ability after intake of kava special extract WS 1490. Z Allgemeinmed 1993;69;271–7.
  30. Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine Communications, 1998, 156–7.
  31. Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002;30:1153–7.